WSJ : Sprint Changes CEOs, Puts Focus on Growing Company

Sprint Changes CEOs, Puts Focus on Growing Company
Dan Hesse Is Out, Entrepreneur Marcelo Claure Is In as Carrier Drops T-Mobile Bid

Sprint Corp. S -16.62% on Wednesday replaced Chief Executive Dan Hesse with billionaire entrepreneur Marcelo Claure, and said its focus is on building the business.

"While we continue to believe industry consolidation will enhance competitiveness and benefit customers, our focus moving forward will be on making Sprint the most successful carrier," said Sprint Chairman Masayoshi Son.

The comments suggest the wireless carrier is prepared to go it alone. According to people familiar with the matter, the company decided Tuesday to end its pursuit of T-Mobile US Inc. TMUS -8.05% in the face of stiff opposition from regulators.

The T-Mobile decision, made at a Sprint board meeting Tuesday, puts an end to a deal that would have valued T-Mobile at $32 billion and created a more muscular rival to market leaders Verizon Communications Inc. VZ -1.66% and AT&T Inc. T -1.25%

Instead, Sprint will have to try to bulk up the hard way—by launching a fierce fight to rebuild its subscriber rolls after shedding customers for years.

The man charged with leading the improvement, Mr. Claure, will start Monday. He will receive a base salary of $1.5 million and a $500,000 signing bonus, and will be eligible for bonuses that could at least triple his salary.

A Bolivian soccer fan, the 43-year-old Mr. Claure built mobile phone distributor Brightstar Corp. into a company with more than $10 billion in revenue and a presence in more than 50 countries. SoftBank Corp. 9984.TO -3.50% , which also has a commanding stake in Sprint, bought control of Brightstar in January to give it more clout with makers of mobile phones and put Mr. Claure on Sprint's board.

Mr. Claure will have his work cut out for him. An extensive network overhaul has hurt service quality and made it difficult for the country's third-largest wireless carrier to recruit customers aggressively. But much of that work is now done, and Sprint said last week that it is testing new price plans in preparation for a strong push later this year.

Whether it can succeed is an open question. The company has lost money every year back to 2007, the fallout of a disastrous merger with Nextel that left it saddled with disparate network technologies and poor customer service. The company was taken over more than a year ago by SoftBank, but the Japanese company's chief executive, Mr. Son, has struggled to change Sprint's culture.

Meanwhile, it will face an invigorated competitor in T-Mobile. Sprint's erstwhile merger partner has added more than 4 million of the industry's lucrative postpaid customers over the past five quarters and may attract new suitors. Iliad SA, which disrupted the French market with ultra cheap wireless plans, has offered to pay $15 billion for control of the company, and satellite television operator Dish Network Corp.'s chairman, Charlie Ergen has said he would be interested in T-Mobile if Sprint's deal fell through.

Sprint's shares fell 19% in morning trading, while T-Mobile dropped more than 9%.

The decision to abandon the deal at least will spare Sprint what was shaping up to be a long, distracting and potentially fruitless antitrust battle. The carriers had been working on a deal for months. But regulators had been working hard as well to head off further consolidation of the already highly concentrated U.S. wireless industry.

Their concern: A deal to combine the country's third- and fourth-largest wireless carriers would have left consumers with fewer choices for service, particularly at the low end of the market.

When Messrs. Son and Hesse met officials at the Justice Department and Federal Communications Commission over the winter, they were given the signal that a deal would face high hurdles. Last week, the FCC punctuated its opposition by saying it would propose rules that would prevent Sprint and T-Mobile from bidding together in a crucial coming spectrum auction.

Mr. Son, who had been driving the effort, worked hard to press his case. He appeared on Charlie Rose and at conferences promising an alternative to what he considers America's backward wireless networks and saying he needed scale to mount a real fight with Verizon and AT&T.

He also amassed a deep bench of advisers in Washington, including lobbyist David Carmen, former senator Bob Kerrey, and Tony Podesta, a lobbyist whose brother John is a senior counselor to President Obama.

Yet Mr. Son came to the decision over the past few weeks that moving forward with the bid was too risky, people familiar said. A deal would need to clear not only an antitrust review at the Justice Department, but also a public interest vetting by the FCC. Three years ago, it was opposition from the FCC that put the nail in the coffin of AT&T's $39 billion deal to buy T-Mobile.

Jonathan Chaplin, an analyst at New Street Research, said Sprint's decision was "a step in the right direction," and the companies could revisit a tie-up when the regulatory environment was less hostile. Dropping the bid now would allow Sprint to finish turning itself around and avoid nearly two years of uncertainty.

The decision to bow to government pressure is the latest development in what has been a wild year for media and telecom, including Comcast Corp.'s planned $45 billion acquisition of Time Warner Cable TWC -0.67% and AT&T's $49 billion deal for DirecTV. DTV -0.40% It comes on a day when 21st Century Fox abandoned its effort to buy Time Warner Inc. for about $80 billion and will surely disappoint the scores of bankers and lawyers representing the multiple parties with stakes in the deal.

Since buying control of Sprint, Mr. Son has found it more difficult than he anticipated to change the stodgy culture of a telecom company based in Overland Park, Kan., that he said had a "loser" mentality. Mr. Son opened an office in San Carlos, Calif., and brought SoftBank engineers from Japan to help guide the turnaround.

His brash personality rubbed some Sprint executives the wrong way, however, and there has been a series of departures in the sales, marketing and network departments.

"Masa and I are very different and we don't always agree," wrote Mr. Hesse in an email to the Journal earlier this year, using Mr. Son's nickname. "But we respect each other a great deal and we communicate that respect to one another regularly."

—Gillian Tan and Thomas Gryta contributed to this article.

>>> Qatar walks away from record $90M UES townhouse contract

The nation of Qatar has pulled the plug on a $90 million purchase of an Upper East Side townhouse at 19 East 64th Street, putting an end to what would have been the city’s priciest commercial townhouse deal, The Real Deal has learned.

In January, Qatar, represented by Douglas Elliman’s Oren and Tal Alexander, entered into contract to buy the 20,500-square-foot townhouse from the Wildenstein family with the intention of using it as a consulate, as TRD reported. At the time, the Alexanders said the contract was for $100 million, but a source familiar with the property confirmed yesterday that the contract was for $90 million.

The Wildensteins, who are prominent New York City art dealers, were being represented by the Corcoran Group’s Carrie Chiang. They were using the townhouse as an art gallery, but it now lies vacant, and questions remain as to whether they will look for a new buyer.

The closing was slated for late June. Shortly before then, however, lawyers representing Qatar approached the Wildensteins and indicated that the deal could die, according to a well-placed source. A new closing date was set for late July, but once again the Qataris’ lawyers expressed that their clients were not going to complete the acquisition.

“The deal did not close as scheduled,” a spokesperson for the Wildensteins told TRD yesterday, but declined to comment further.

When approached by TRD last month, Oren Alexander said that he was “patiently waiting for closing.” He cited certificate of occupancy issues as a reason for the delay, but insisted that the deal would be sealed in July. Chiang didn’t respond to requests for comment.

This week, both Alexander brothers did not respond to multiple requests for comment. The deal, which they aggressively publicized when it went into contract, would have been the largest single sale of their careers.

Ahmed Yousef Al-Rumaihi, consul general for the state of Qatar in New York, told TRD in a statement in January that the property was in “move-in condition.” But he couldn’t be reached for comment this week.

What caused the Qataris to get cold feet remains unclear. It’s unlikely to be an issue of money – the nation’s sovereign wealth fund has about $170 billion in assets under management, according to the Sovereign Wealth Fund Institute. And Qatari royals have shown a penchant for buying trophy Manhattan real estate, including the $35 million Ellen Biddle Shipman Residence at Beekman Place, a $47 million townhouse at 22 East 71st Street formerly owned by Aby Rosen, and multiple apartments at Gary Barnett’s One57, according to news reports.

But sources speculated the Qatari government may be looking to lower its profile, in the light of severe criticism heaped against it after a report concluded that hundreds of migrant construction workers have died due to poor working conditions in the oil-rich nation. A recent ESPN documentary estimated that, at the current rate, more than 4,000 migrant workers will die by 2022, by the time Qatar hosts the FIFA World Cup.

In anticipation of the closing, the Wildensteins had already vacated the art gallery and cleaned out the space, a source said. It’s uncertain what the fate of the property will be, and the Wildensteins’ spokesperson declined to comment about whether the family would pursue litigation.

(BFW) AstraZeneca, Shire Fall; U.S. Treasury Examines Inversion Limits


AstraZeneca, Shire Fall; U.S. Treasury Examines Inversion Limits
2014-08-06 13:29:53.381 GMT


By Gaurav Panchal
Aug. 6 (Bloomberg) -- AstraZeneca, which saw a failed
takeover bid from Pfizer in May, trades as much as 4.7% lower,
most since May 19, while AbbVie takeover target Shire trades as
much as 6.7% lower, leading decliners in SXDP index.
* Yday after European market close, report U.S. Treasury
examining inversion limits without Congress action
* Shire trading ~13% below AbbVie’s cash, stock offer based on
yday close for AbbVie
* July 18: AbbVie had said expected deal to to reduce
effective tax rate to ~13% by 2016; deal includes
various break fee payment events
* NOTE: Washington Backlash on Tax Inversion-Driven M&A Comes
to Fore: Bloomberg Intelligence
* Earlier: Biggest U.S. drugstore chain Walgreen said it plans
to pay about $15.3b for part of Alliance Boots it doesn’t
already own, and won’t use the deal to move its tax address
abroad
* NOTE: Stoxx 600 trades 1.5% lower; SXDP down 2.4%, most
since April, sector 2nd biggest faller in Europe

For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
Gaurav Panchal in London at +44-20-7392-0511 or
gpanchal2@bloomberg.net
Andrew Rummer

(BFW) *FINEDINING RAISES OFFER FOR WMF PREF SHRS TO EU58 FROM EU53/SHR


BFW 08/06 13:07 *FINEDINING RAISES OFFER FOR WMF PREF SHRS TO EU58 FROM EU53/SHR
BN 08/06 13:06 *FINEDINING COMMENTS IN OTS STATEMENT
BN 08/06 13:05 *FINEDINING EXTENDS OFFER FOR WMF PREF SHARES UNTIL AUG. 25
BN 08/06 13:05 *FINEDINING RAISES OFFER FOR WMF PREF SHARES TO EURO 58/SHARE
BN 08/06 13:04 *OFFER FOR WMF PREF SHARES RAISED

FINEDINING RAISES OFFER FOR WMF PREF SHARES TO EU58/SHR (GER)
2014-08-06 13:11:12.49 GMT

(The following press release from Finedining Capital was received by
e-mail. It was not confirmed by the sender.)


Erwerbsangebot für die Vorzugsaktien der WMF AG erhöht - Annahmefrist
verlängert bis zum 25. August 2014

München (ots) -

- Angebotspreis erhöht auf 58 Euro je Vorzugsaktie
- Annahmefrist verlängert bis zum 25. August 2014
- Angebot entspricht einem Aufschlag von etwa 22 Prozent auf den
volumengewichteten Drei-Monats-Durchschnittskurs der
WMF-Vorzugsaktien. Es entspricht darüber hinaus einem Aufschlag
von etwa 82 Prozent auf den von Finedining Capital im Rahmen des
freiwilligen öffentlichen Übernahmeangebots im Jahr 2012
bezahlten Einstiegspreis für die WMF-Vorzugsaktien
- Bis heute haben die Aktionäre das Angebot bereits für mehr als
35 Prozent der ausstehenden Vorzugsaktien angenommen oder ihre
Annahme zugesagt. Das entspricht etwa 47 Prozent der
Vorzugsaktien, die für die Erreichung der Angebotsbedingung
notwendig sind

06. August 2014 - Finedining Capital GmbH ("Finedining Capital"),
eine Holdinggesellschaft im mittelbaren Besitz von durch KKR
(gemeinsam mit verbundenen Unternehmen "KKR") beratenen Fonds, hat
den Angebotspreis für den Erwerb aller ausstehenden Vorzugsaktien
(ISIN DE0007803033) der WMF AG ("WMF") von 53 Euro auf 58 Euro pro
Aktie erhöht. Die Annahmefrist verlängert sich bis zum 25. August
2014 um 24.00 Uhr (MEZ). Eine weitere Fristverlängerung durch die
Bieterin ist aus rechtlichen Gründen ausgeschlossen. Ferner ist eine
weitere Erhöhung des Angebotspreises ab dem 9. August 2014 nicht mehr
möglich. Das freiwillige öffentliche Erwerbsangebot bleibt ansonsten
unverändert. Bis heute haben die Aktionäre das Angebot bereits für
mehr als 35 Prozent der ausstehenden Vorzugsaktien angenommen oder
ihre Annahme zugesagt. Das entspricht etwa 47 Prozent der
Vorzugsaktien, die für die Erreichung der Angebotsbedingung notwendig
sind. Die Bieterin geht weiterhin davon aus, dass das öffentliche
Erwerbsangebot Ende August vollzogen werden kann, nachdem alle
kartellrechtlichen Genehmigungen erteilt wurden. Das Bundeskartellamt
hat den Vollzug des Vorhabens bereits am 31. Juli 2014 freigegeben.

Die Besitzer von WMF-Vorzugsaktien erhalten unter dem geänderten
öffentlichen Erwerbsangebot einen Aufschlag von etwa 22 Prozent auf
den volumengewichteten Drei-Monats-Durchschnittskurs der
WMF-Vorzugsaktien. Das Angebot entspricht darüber hinaus einem
Aufschlag von etwa 82 Prozent auf den von Finedining Capital im
Rahmen des freiwilligen öffentlichen Übernahmeangebots im Jahr 2012
bezahlten Einstiegspreis für die WMF-Vorzugsaktien. Die
WMF-Vorzugsaktie notierte mindestens in den vergangenen 40 Jahren nie
auf dem Niveau des jetzigen erhöhten Angebots.

Ziel ist es, eine Beteiligung von mindestens 90 Prozent des
WMF-Grundkapitals zu erreichen, um im Rahmen eines Squeeze-outs die
Anteile der Minderheitsaktionäre gegen eine angemessene Barabfindung
erwerben zu können. Das Angebot ist daher an die Bedingung geknüpft,
dass durch das Angebot, die Zusammenlegung der Aktien von Finedining
Capital und FIBA Beteiligungs- und Anlage GmbH ("FIBA") sowie
etwaiger Erwerbe außerhalb des Angebots eine Beteiligungsquote von
mindestens 90 Prozent - ausgenommen der von WMF gehaltenen eigenen
Aktien - erreicht wird. Dies ist der Fall, wenn etwa 75 Prozent der
ausstehenden Vorzugsaktien während der Angebotsfrist angedient oder
parallel hinzuerworben werden. Zudem unterliegt das Angebot der
Zustimmung der relevanten Aufsichtsbehörden.

KKR und FIBA sind der Überzeugung, dass WMF von der geplanten
Vereinfachung der Gesellschaftsstruktur profitieren und die
Neustrukturierung WMF dabei unterstützen wird, die vom Management
eingeleitete langfristige Wachstumsstrategie des Unternehmens
fortzusetzen. Die Börsennotierung bietet derzeit keine wesentlichen
Vorteile für WMF, sondern nimmt vielmehr in beträchtlichem Umfang
Zeit des Managements in Anspruch.

Angebotsunterlage und Angebotsänderung stehen unter
www.finedining-offer.com zur Verfügung. Dort können auch weitere
Informationen abgerufen werden. Kopien der Angebotsunterlage und der
Angebotsänderung sowie eine unverbindliche Übersetzung in englischer
Sprache sind bei der Deutsche Bank Aktiengesellschaft, ICSS, Issuer
Services, Post-IPO Services, Taunusanlage 12, 60325 Frankfurt am
Main, Deutschland, kostenlos erhältlich (Bestellung via Fax: +49(0)69
910-38794; Bestellung via E-Mail: dct.tender-offers@db.com, unter
Angabe der vollständigen Postadresse).

(BFW) GSK Says Patient Treated With Arzerra Had Fatal Reaction


GSK Says Patient Treated With Arzerra Had Fatal Reaction
2014-08-06 12:30:17.828 GMT


By Jurjen van de Pol
Aug. 6 (Bloomberg) -- GlaxoSmithKline says a severe
infusion reaction resulting in death was reported in a patient
with chronic lymphocytic leukemia who was given Arzerra.

Link to Statement:{NSN N9VWQH3S3GU8 <GO>}
Link to Company News:{GSK LN <Equity> CN <GO>}

For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact the reporter on this story:
Jurjen van de Pol in Frankfurt at +49-69-9204-1104 or
jvandepol@bloomberg.net

To contact the editor responsible for this story:
James Ludden at +44-20-7673-2645 or
jludden@bloomberg.net

>>> Time Warner: Color on FOXA Bid Withdrawal

Time Warner: Color on FOXA Bid Withdrawal

  • Topeka Capital is downgrading TWX to Sell from Hold. Yesterday, after the close, Twenty-First Century Fox (FOXA) withdrew its initial bid to buy TWX, a bid that, based on yesterday's closing price of FOXA, valued TWX at $80.34/share. That said, with the stock only marked down 9.9% from yesterday's close, there is still an inefficient "in-play" premium built into TWX shares, which in firm's view, needs to be unwound. Tgt moves from $71 to $69.
  • FBR Capital notes, as Fox trots away from its bid for Time Warner, citing the 11% decline in its stock and Time Warner's refusal to negotiate, firm sees a dimming of merger fever in content stocks. Not just for the Time Warner pairing. But the broader concept of a big consolidation wave among TV content suppliers. Consolidation is at times a follow-the-leader exercise. And the combination of two of the biggest players would have motivated other TV content companies to focus more on the need for mergers to gain scale, even though that argument was never part of Fox's case for Time Warner. Lacking that example, content companies will tend to shift back to business as usual.
  • TWX reported earnings this morning and FOXA reports after the close.
Shares of TWX are down approx 14% in pre-market; shares of FOXA are up approx 8%.

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: FUEL -24.2%, GMED -19%, NUS -17%, GRPN -16.3%, FRGI -13.9%, CTSH -11.9%, TWX -11.1%, TTWO -7%, RLD -6.2%, ARIA -5.3%, PRAA -4.7%, CEQP -4.4%, CHUY -3.9%, FSLR -3.4%, PZZA -3.1%, IPXL -3.1%, PERI -3.1%, TI -3%, SGY -2.5%, Z -2.2%, CHK -2.1%, ANR -2%, XXIA -1.4%, KFX -1.4%, DPM -1.3%, GWPH -1.3%,CLR -1.2%, JCOM -1.2%, TRGT -1.1%, TRGT -1.1%, AVNR -1%, .

M&A news: S -13.7% (reports that co is abandoning its pursuit of T-Mobile (TMUS); T-Mobile shares also lower by 7.8%), TWX -11.1% (21st Century Fox withdraws its proposal to acquire Time Warner Inc), WAG -10.2% (to acquire remaining 55% of Alliance Boots that it does not currently own, not inversion related; establishes new adjusted EPS goal for fiscal 2016, announces buyback),TMUS -7.7% (following late move higher on reports of improved Iliad offer and/or joint DISH bid).

Select financial related names showing weakness: NBG -3.3%, RBS -1.6%, BCS -1.1%, DB -1%, LYG -0.8%, JPM -0.6%.

Other news: CYTX -28.6% (placed enrollment in the ATHENA and ATHENA II trials on clinical hold; anticipates that it will not be possible to complete enrollment of the ATHENA I trial prior to the end of 2014 as previously anticipated), CTP -5.5% (filed for a $50 mln common stock offering and for an offering of ~404.8K shares of common stock by a selling stockholder), SHPG -4.2% (volatility surrounding M&A spec), TSLX -3.8% (prices 5 mln shares of common stock by certain stockholders at $18.63 per share), PT -3.4% (EU concerns after Italy enters recession (Q2 GDP -0.2%, Q1 -0.1%)), SNN -3% (volatility surrounding M&A spec), AZN -2.6% (volatility surrounding M&A spec), MANU -2.3% (upsizes offering by 4 mln share and prices 12 mln shares of ordinary shares at $17.00 per share, all by selling shareholders), COUP -2.2% (following GRPN results), HLF -1.7% (NUS peer), SNCR -1.5% (to offer $200 mln of convertible senior notes).

Analyst comments: VNR -1.8% (downgraded to Hold at Wunderlich ), TGT -1.3% (downgraded to Neutral from Buy at Goldman), BYI -1.1% (downgraded to Hold at Stifel), PEP -0.4% (initiated with a Reduce at Nomura).

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
: ENPH +19.1%, ZGNX +15.7%, CRTO +11.5%, OXGN +9.9%, ATSG +9%, DRYS +7%, ZEN +7%, WPX +6%, MCHX +5.6%, ZAGG +5.3%, PAYC +5.2%, ATVI +4.2%, SGMS +4.2%, TC +4%, NSM +4%, MPO +3.8%, AOL +3.8%, MODN +3.4%, PEGA +3.3%, JAZZ +3.1%, ORIG +3.1%, PBPB +2.9%, THI +2.9%, OAS +2.7%, NYMT +2.5%,AXLL +1.9%, CNP +1.9%, AXAS +1.6%, TTGT +1.5%, AVA +1.5%, SNTA +1.3%, ING +1.2%, NSTG +1.1%, WTR +1.1%, .

M&A news: FOXA +7.8% (21st Century Fox withdraws its proposal to acquire Time Warner Inc), PEOP +6.8% (Independent Bank Corp. and Peoples Federal Bancshares, Inc. Sign Definitive Merger Agreement for Acquisition of Peoples Federal Bancshares), CERN +1.9% (Cerner to acquire Siemens (SIEGY) Health Services for $1.3 bln).

Other news: ATSG +9% (Board of Directors approves share repurchase authorization for up to $50 mln of co's common shares; co to acquire two Boeing (BA) 767-300s currently leased by ABX Air), CANF +3.7% (new data shows high efficacy for Can-Fite's CF101 in Rheumatoid Arthritis and Psoriasis patients), TKMR +3.3% (continued ebola driven momentum due), MOVE +2.6% (still checking, may be related to M&A rumors in the space), VOD +1.3% (reacting to fall thru M&A in the space), ADP +1.1% (authorized to purchase an additional 30 mln shares of its common stock), NSTG +1.1% (received market approval from the Australian Therapeutic goods administration for its Prosigna breast cancer prognostic gene signature assay), MNKD +1% (disclosed supply agreement with Amphastar).

Analyst comments: AKRX +2.2% (target raised to $45 from $33 at Piper Jaffray), RNG +1.6% (initiated with a Outperform at Oppenheimer), GE +0.7% (upgraded to Outperform from Mkt Perform at Bernstein)

>>> Mondelez Int'l beats by $0.01, misses on revs; guides FY14 EPS in-line

Mondelez Int'l beats by $0.01, misses on revs; guides FY14 EPS in-line

Reports Q2 (Jun) earnings of $0.40 per share, $0.01 better than the Capital IQ Consensus Estimate of $0.39; revenues fell 1.8% year/year to $8.44 bln vs the $8.68 bln consensus.
  • Co issues in-line guidance for FY14, sees EPS of $1.73-1.78 vs. $1.72 Capital IQ Consensus Estimate.
  • "Our top line remains challenged by a combination of weaker category growth and some temporary customer and consumer dislocations, as we lead pricing in many of our key markets and categories. We anticipate revenue growth to improve in the second half as coffee pricing headwinds reverse and we cycle more favorable comparisons in China, but we expect the challenging operating environment to continue. As a result, we expect Organic Net Revenue growth in the range of 2 to 2.5 percent for the full year, down from our previous expectation of approximately 3 percent."